{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T11:01:59Z","timestamp":1768820519955,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":2109,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1074\/jbc.m114.608091","type":"journal-article","created":{"date-parts":[[2014,10,21]],"date-time":"2014-10-21T06:09:12Z","timestamp":1413871752000},"page":"33927-33944","source":"Crossref","is-referenced-by-count":71,"title":["The Spleen Tyrosine Kinase (Syk) Regulates Alzheimer Amyloid-\u03b2 Production and Tau Hyperphosphorylation"],"prefix":"10.1016","volume":"289","author":[{"given":"Daniel","family":"Paris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghania","family":"Ait-Ghezala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corbin","family":"Bachmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Laco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Beaulieu-Abdelahad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M114.608091_bib1","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/NEN.0b013e31825018f7","article-title":"Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature","volume":"71","author":"Nelson","year":"2012","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1074\/jbc.M114.608091_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/JAD-2012-111361","article-title":"Amyloid-\u03b2 oligomers in cerebrospinal fluid are associated with cognitive decline in patients with Alzheimer's disease","volume":"29","author":"Santos","year":"2012","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.M114.608091_bib3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.0b013e3182661f74","article-title":"Amyloid-\u03b2 assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study","volume":"79","author":"Doraiswamy","year":"2012","journal-title":"Neurology"},{"key":"10.1074\/jbc.M114.608091_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2741\/E605","article-title":"Genetics of familial and sporadic Alzheimer's disease","volume":"5","author":"Piaceri","year":"2013","journal-title":"Front. Biosci"},{"key":"10.1074\/jbc.M114.608091_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-12-385883-2.00012-6","article-title":"Alzheimer's disease and the amyloid \u03b2-protein","volume":"107","author":"Walsh","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci"},{"key":"10.1074\/jbc.M114.608091_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer's disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.1074\/jbc.M114.608091_bib7","doi-asserted-by":"crossref","first-page":"1518.e1","DOI":"10.1016\/j.neurobiolaging.2012.09.017","article-title":"Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population","volume":"34","author":"Kero","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.M114.608091_bib8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/humu.20336","article-title":"Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased A\u03b242 and decreased A\u03b240","volume":"27","author":"Kumar-Singh","year":"2006","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.M114.608091_bib9","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1074\/jbc.M111.264473","article-title":"Structural basis for increased toxicity of pathological A\u03b242:A\u03b240 ratios in Alzheimer disease","volume":"287","author":"Pauwels","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.tips.2013.03.002","article-title":"The case for soluble A\u03b2 oligomers as a drug target in Alzheimer's disease","volume":"34","author":"Hefti","year":"2013","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1074\/jbc.M114.608091_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1006\/bbrc.2000.3051","article-title":"Oligomerization and toxicity of \u03b2-amyloid-42 implicated in Alzheimer's disease","volume":"273","author":"El-Agnaf","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1074\/jbc.M114.608091_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0304-3940(92)90774-2","article-title":"Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of Tau: generation of paired helical filament epitopes and neuronal localisation of the kinase","volume":"147","author":"Hanger","year":"1992","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M114.608091_bib13","doi-asserted-by":"crossref","first-page":"25457","DOI":"10.1074\/jbc.M603469200","article-title":"The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in Tau hyperphosphorylation","volume":"281","author":"Plattner","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib14","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.3233\/JAD-2012-129025","article-title":"GSK3 and Tau: two convergence points in Alzheimer's disease","volume":"33","author":"Hernandez","year":"2013","journal-title":"J. Alzheimers Dis"},{"key":"10.1074\/jbc.M114.608091_bib15","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI64516","article-title":"Inhibition of GSK3\u03b2-mediated BACE1 expression reduces Alzheimer-associated phenotypes","volume":"123","author":"Ly","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1074\/jbc.M114.608091_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.2353\/ajpath.2008.070904","article-title":"Amyloid activates GSK-3\u03b2 to aggravate neuronal Tauopathy in bigenic mice","volume":"172","author":"Terwel","year":"2008","journal-title":"Am. J. Pathol"},{"key":"10.1074\/jbc.M114.608091_bib17","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front. Mol. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib18","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol. Med"},{"key":"10.1074\/jbc.M114.608091_bib19","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2011.03.048","article-title":"Selective dihydropyiridine compounds facilitate the clearance of \u03b2-amyloid across the blood-brain barrier","volume":"659","author":"Bachmeier","year":"2011","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.M114.608091_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.brainres.2003.11.061","article-title":"Nilvadipine antagonizes both A\u03b2 vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice","volume":"999","author":"Paris","year":"2004","journal-title":"Brain Res"},{"key":"10.1074\/jbc.M114.608091_bib21","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gps.2638","article-title":"Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study","volume":"26","author":"Kennelly","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1074\/jbc.M114.608091_bib22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/gps.2735","article-title":"Apolipoprotein E genotype-specific short-term cognitive benefits of treatment with the antihypertensive nilvadipine in Alzheimer's patients\u2013an open-label trial","volume":"27","author":"Kennelly","year":"2012","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1074\/jbc.M114.608091_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MNM.0b013e32804c58aa","article-title":"Favorable effects of nilvadipine on cognitive function and regional cerebral blood flow on SPECT in hypertensive patients with mild cognitive impairment","volume":"28","author":"Hanyu","year":"2007","journal-title":"Nucl. Med. Commun"},{"key":"10.1074\/jbc.M114.608091_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jps.2600760410","article-title":"Determination of (+)- and (\u2212)-nilvadipine in human plasma using chiral stationary-phase liquid chromatography and gas chromatography-mass spectrometry, and a preliminary pharmacokinetic study in humans","volume":"76","author":"Tokuma","year":"1987","journal-title":"J. Pharm. Sci"},{"key":"10.1074\/jbc.M114.608091_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0021-9673(94)00832-T","article-title":"Stereoselective pharmacokinetics of dihydropyridine calcium antagonists","volume":"694","author":"Tokuma","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1074\/jbc.M114.608091_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1248\/cpb.42.950","article-title":"Studies on nilvadipine. IV. Synthesis of deuterated and optically active isopropyl 2-cyano-3-methoxycarbonyl-4-(3-nitrophenyl)-6-methyl-1,4-dihydropyridine-5-carboxylate (nilvadipine)","volume":"42","author":"Satoh","year":"1994","journal-title":"Chem. Pharm. Bull"},{"key":"10.1074\/jbc.M114.608091_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/jm00001a017","article-title":"Calcium entry blockers and activators: conformational and structural determinants of dihydropyrimidine calcium channel modulators","volume":"38","author":"Rovnyak","year":"1995","journal-title":"J. Med. Chem"},{"key":"10.1074\/jbc.M114.608091_bib28","first-page":"249","article-title":"Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog","volume":"63","author":"Tokuma","year":"1989","journal-title":"Res. Commun. Chem. Pathol. Pharmacol"},{"key":"10.1074\/jbc.M114.608091_bib29","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1016\/S0021-9258(17)32449-3","article-title":"Evidence that production and release of amyloid \u03b2-protein involves the endocytic pathway","volume":"269","author":"Koo","year":"1994","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2006.12.029","article-title":"Inhibition of A\u03b2 production by NF-\u03baB inhibitors","volume":"415","author":"Paris","year":"2007","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M114.608091_bib31","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10616-010-9313-x","article-title":"Characterization and use of human brain microvascular endothelial cells to examine \u03b2-amyloid exchange in the blood-brain barrier","volume":"62","author":"Bachmeier","year":"2010","journal-title":"Cytotechnology"},{"key":"10.1074\/jbc.M114.608091_bib32","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1549-8719.2011.00096.x","article-title":"Epitope-dependent effects of \u03b2-amyloid antibodies on \u03b2-amyloid clearance in an in vitro model of the blood-brain barrier","volume":"18","author":"Bachmeier","year":"2011","journal-title":"Microcirculation"},{"key":"10.1074\/jbc.M114.608091_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s12031-012-9866-6","article-title":"Stimulation of the retinoid X receptor facilitates \u03b2-amyloid clearance across the blood-brain barrier","volume":"49","author":"Bachmeier","year":"2013","journal-title":"J. Mol. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mcn.2013.06.004","article-title":"Role of the cannabinoid system in the transit of \u03b2-amyloid across the blood-brain barrier","volume":"56","author":"Bachmeier","year":"2013","journal-title":"Mol. Cell. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med"},{"key":"10.1074\/jbc.M114.608091_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-7-17","article-title":"Reduction of \u03b2-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease","volume":"7","author":"Paris","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1074\/jbc.M114.608091_bib37","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ejphar.2011.09.019","article-title":"Anatabine lowers Alzheimer's A\u03b2 production in vitro and in vivo","volume":"670","author":"Paris","year":"2011","journal-title":"Eur. J. Pharmacol"},{"key":"10.1074\/jbc.M114.608091_bib38","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/abio.1998.2770","article-title":"Site-specific, enzymatic biotinylation of recombinant proteins in Spodoptera frugiperda cells using biotin acceptor peptides","volume":"262","author":"Duffy","year":"1998","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M114.608091_bib39","first-page":"1138","article-title":"Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli","volume":"11","author":"Schatz","year":"1993","journal-title":"Biotechnology"},{"key":"10.1074\/jbc.M114.608091_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","article-title":"Synapse loss and microglial activation precede tangles in a P301S Tauopathy mouse model","volume":"53","author":"Yoshiyama","year":"2007","journal-title":"Neuron"},{"key":"10.1074\/jbc.M114.608091_bib41","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.neurobiolaging.2012.05.010","article-title":"Sensitive quantitative assays for Tau and phospho-Tau in transgenic mouse models","volume":"34","author":"Acker","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1074\/jbc.M114.608091_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4172\/2168-975X.1000126","article-title":"Anatabine attenuates Tau phosphorylation and oligomerization in P301S Tau transgenic mice","volume":"3","author":"Paris","year":"2014","journal-title":"Brain Disord. Ther"},{"key":"10.1074\/jbc.M114.608091_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.06.029","article-title":"Targeting TNF: a therapeutic strategy for Alzheimer's disease","author":"Cheng","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1074\/jbc.M114.608091_bib44","doi-asserted-by":"crossref","first-page":"24573","DOI":"10.1074\/jbc.M111.333054","article-title":"Nuclear factor-\u03baB regulates \u03b2APP and \u03b2- and \u03b3-secretases differently at physiological and supraphysiological A\u03b2 concentrations","volume":"287","author":"Chami","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib45","doi-asserted-by":"crossref","first-page":"F571","DOI":"10.1152\/ajprenal.00113.2014","article-title":"Rho-kinase regulation of TNF-\u03b1-induced nuclear translocation of NF-\u03baB RelA\/p65 and M-CSF expression via p38 MAPK in mesangial cells","volume":"307","author":"Matoba","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol"},{"key":"10.1074\/jbc.M114.608091_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2014.03.037","article-title":"Sulforaphane inhibits phorbol ester-stimulated IKK-NF-\u03baB signaling and COX-2 expression in human mammary epithelial cells by targeting NF-\u03baB activating kinase and ERK","volume":"351","author":"Kim","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1074\/jbc.M114.608091_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0161-5890(95)00134-4","article-title":"Regulation of BCR- and PKC\/Ca2+-mediated activation of the Raf1\/MEK\/MAPK pathway by protein-tyrosine kinase and -tyrosine phosphatase activities","volume":"33","author":"Kawauchi","year":"1996","journal-title":"Mol. Immunol"},{"key":"10.1074\/jbc.M114.608091_bib48","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/01635580903285080","article-title":"Piceatannol inhibits phorbol ester-induced NF-\u03baB activation and COX-2 expression in cultured human mammary epithelial cells","volume":"61","author":"Liu","year":"2009","journal-title":"Nutr. Cancer"},{"key":"10.1074\/jbc.M114.608091_bib49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/jlb.63.5.636","article-title":"IgA Fc receptor (CD89) activation enables coupling to Syk and Btk tyrosine kinase pathways: differential signaling after IFN-\u03b3 or phorbol ester stimulation","volume":"63","author":"Launay","year":"1998","journal-title":"J. Leukocyte Biol"},{"key":"10.1074\/jbc.M114.608091_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2443.2001.00434.x","article-title":"Requirement of Syk-phospholipase C-\u03b32 pathway for phorbol ester-induced phospholipase D activation in DT40 cells","volume":"6","author":"Hitomi","year":"2001","journal-title":"Genes Cells"},{"key":"10.1074\/jbc.M114.608091_bib51","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.4049\/jimmunol.163.12.6785","article-title":"Syk activation initiates downstream signaling events during human polymorphonuclear leukocyte phagocytosis","volume":"163","author":"Raeder","year":"1999","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.M114.608091_bib52","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/leu.2013.89","article-title":"SYK regulates mTOR signaling in AML","volume":"27","author":"Carnevale","year":"2013","journal-title":"Leukemia"},{"key":"10.1074\/jbc.M114.608091_bib53","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/onc.2008.493","article-title":"The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells","volume":"28","author":"Zhou","year":"2009","journal-title":"Oncogene"},{"key":"10.1074\/jbc.M114.608091_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1744-8069-7-42","article-title":"Central nervous system mast cells in peripheral inflammatory nociception","volume":"7","author":"Xanthos","year":"2011","journal-title":"Mol. Pain"},{"key":"10.1074\/jbc.M114.608091_bib55","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1124\/jpet.103.052316","article-title":"The orally available spleen tyrosine kinase inhibitor 2-[7-(3,4-dimethoxyphenyl)-imidazo[1,2-c]pyrimidin-5-ylamino]nicotinamide dihydrochloride (BAY 61-3606) blocks antigen-induced airway inflammation in rodents","volume":"306","author":"Yamamoto","year":"2003","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1074\/jbc.M114.608091_bib56","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbamcr.2007.11.005","article-title":"The microtubule-associated protein Tau is phosphorylated by Syk","volume":"1783","author":"Lebouvier","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.608091_bib57","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1074\/jbc.M114.608091_bib58","doi-asserted-by":"crossref","first-page":"9356","DOI":"10.1128\/MCB.20.24.9356-9363.2000","article-title":"Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3\u03b2","volume":"20","author":"Li","year":"2000","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/jbc.M114.608091_bib59","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1073\/pnas.96.12.6890","article-title":"The tyrosine kinases Syk and Lyn exert opposing effects on the activation of protein kinase Akt\/PKB in B lymphocytes","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M114.608091_bib60","doi-asserted-by":"crossref","first-page":"10870","DOI":"10.1074\/jbc.M112.426130","article-title":"Syk inhibits the activity of protein kinase A by phosphorylating tyrosine 330 of the catalytic subunit","volume":"288","author":"Yu","year":"2013","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib61","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jamaneurol.2014.1646","article-title":"Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study","volume":"71","author":"Gottesman","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1074\/jbc.M114.608091_bib62","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","article-title":"Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial","volume":"352","author":"Forette","year":"1998","journal-title":"Lancet"},{"key":"10.1074\/jbc.M114.608091_bib63","first-page":"1083","article-title":"Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study","volume":"92","author":"Seux","year":"1999","journal-title":"Arch. Mal. Coeur Vaiss"},{"key":"10.1074\/jbc.M114.608091_bib64","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1074\/jbc.M706579200","article-title":"NF\u03baB-dependent control of BACE1 promoter transactivation by A\u03b242","volume":"283","author":"Buggia-Prevot","year":"2008","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-6-1","article-title":"\u03b2-Amyloid oligomers and fibrils stimulate differential activation of primary microglia","volume":"6","author":"Sondag","year":"2009","journal-title":"J. Neuroinflammation"},{"key":"10.1074\/jbc.M114.608091_bib66","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1523\/JNEUROSCI.17-07-02284.1997","article-title":"Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia","volume":"17","author":"McDonald","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib67","doi-asserted-by":"crossref","first-page":"20842","DOI":"10.1074\/jbc.M600627200","article-title":"Fibrillar \u03b2-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia","volume":"281","author":"Wilkinson","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M114.608091_bib68","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"\u03b2-Amyloid stimulation of microglia and monocytes results in TNF\u03b1-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib69","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1523\/JNEUROSCI.19-03-00928.1999","article-title":"Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of \u03b2-amyloid and prion proteins","volume":"19","author":"Combs","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1074\/jbc.M114.608091_bib70","first-page":"587463","article-title":"Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation","volume":"2010","author":"Linnartz","year":"2010","journal-title":"Int. J. Alzheimers Dis"},{"key":"10.1074\/jbc.M114.608091_bib71","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1365-2990.2010.01103.x","article-title":"Tyrosine phosphorylation of Tau accompanies disease progression in transgenic mouse models of Tauopathy","volume":"36","author":"Bhaskar","year":"2010","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1074\/jbc.M114.608091_bib72","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/jnr.23310","article-title":"Attenuation of \u03b2-amyloid-induced Tauopathy via activation of CK2\u03b1\/SIRT1: targeting for cilostazol","volume":"92","author":"Lee","year":"2014","journal-title":"J. Neurosci. Res"},{"key":"10.1074\/jbc.M114.608091_bib73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.neuint.2008.07.007","article-title":"NMDA-induced neuroprotection in hippocampal neurons is mediated through the protein kinase A and CREB (cAMP-response element-binding protein) pathway","volume":"53","author":"Valera","year":"2008","journal-title":"Neurochem. Int"},{"key":"10.1074\/jbc.M114.608091_bib74","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1471-4159.2007.04827.x","article-title":"bFGF promotes photoreceptor cell survival in vitro by PKA-mediated inactivation of glycogen synthase kinase 3\u03b2 and CREB-dependent Bcl-2 up-regulation","volume":"103","author":"O'Driscoll","year":"2007","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M114.608091_bib75","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1471-4159.2011.07330.x","article-title":"Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1","volume":"118","author":"Baxter","year":"2011","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M114.608091_bib76","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1111\/j.1471-4159.2007.04942.x","article-title":"Down-regulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain","volume":"103","author":"Liang","year":"2007","journal-title":"J. Neurochem"},{"key":"10.1074\/jbc.M114.608091_bib77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuropharm.2013.09.015","article-title":"Improvement of spatial memory function in APPswe\/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D","volume":"77","author":"Sierksma","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1074\/jbc.M114.608091_bib78","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbadis.2011.10.004","article-title":"Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model","volume":"1822","author":"Fang","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M114.608091_bib79","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neulet.2006.02.077","article-title":"Nobiletin restoring \u03b2-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer's disease model rats","volume":"400","author":"Matsuzaki","year":"2006","journal-title":"Neurosci. Lett"},{"key":"10.1074\/jbc.M114.608091_bib80","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1172\/JCI22831","article-title":"Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment","volume":"114","author":"Gong","year":"2004","journal-title":"J. Clin. Invest"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820473478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820473478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M114.608091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T04:27:49Z","timestamp":1717475269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820473478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":80,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0021925820473478"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m114.608091","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}